These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 6682104
1. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents. Keller HJ, Keppler B, Schmähl D. J Cancer Res Clin Oncol; 1983; 105(1):109-10. PubMed ID: 6682104 [No Abstract] [Full Text] [Related]
2. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents. Keller HJ, Keppler B, Schmähl D. Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355 [Abstract] [Full Text] [Related]
3. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts. Mattern J, Keppler B, Volm M. Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134 [Abstract] [Full Text] [Related]
4. Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds. Keppler BK, Diez A, Seifried V. Arzneimittelforschung; 1985; 35(12):1832-6. PubMed ID: 4096739 [Abstract] [Full Text] [Related]
5. Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect. Köpf-Maier P, Wagner W, Hesse B, Köpf H. Eur J Cancer (1965); 1981 Jun; 17(6):665-9. PubMed ID: 7308264 [No Abstract] [Full Text] [Related]
9. Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes. Keppler BK, Schmähl D. Arzneimittelforschung; 1986 Dec; 36(12):1822-8. PubMed ID: 3566844 [Abstract] [Full Text] [Related]
11. Autochthonous, acetoxymethylmethylnitrosamine-induced colorectal cancer in rats: a useful tool in selecting new active antineoplastic compounds? Berger MR, Bischoff H, Garzon FT, Schmähl D. Hepatogastroenterology; 1986 Oct; 33(5):227-34. PubMed ID: 3804178 [Abstract] [Full Text] [Related]
12. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions. Venditti JM, Wesley RA, Plowman J. Adv Pharmacol Chemother; 1984 Oct; 20():1-20. PubMed ID: 6398966 [No Abstract] [Full Text] [Related]
13. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II). Wilkoff LJ, Dulmadge EA, Trader MW, Harrison SD, Griswold DP. Cancer Chemother Pharmacol; 1987 Oct; 20(2):96-100. PubMed ID: 3664938 [Abstract] [Full Text] [Related]